PIPER LOCKETT: Open Payments
NPI 1336466101 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 36 payments from 13 companies in 2025. Trend: 2023 $173 · 2024 $410 · 2025 $1,141
Food & beverage: $1,057Education: $84
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $185 |
| Janssen Biotech, Inc. | 7 | $159 |
| ABBVIE INC. | 9 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $141 |
| PFIZER INC. | 5 | $135 |
| Amgen Inc. | 1 | $117 |
| GENZYME CORPORATION | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $45 |
| Ardelyx, Inc. | 1 | $34 |
Products named: TREMFYA, Kerendia, RINVOQ, VELSIPITY, DUPIXENT, UPLIZNA, REZDIFFRA, IBSRELA.
Industry payments across TX — which companies pay providers there.
